e-learning
resources
London 2016
Monday, 05.09.2016
Severe respiratory infections in the intensive care unit and pleural and fungal infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
Christian Niels Meyer (Roskilde, Denmark), Christian Niels Meyer, Karin Armbruster
Source:
International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Session:
Severe respiratory infections in the intensive care unit and pleural and fungal infections
Session type:
Thematic Poster
Number:
2652
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christian Niels Meyer (Roskilde, Denmark), Christian Niels Meyer, Karin Armbruster. Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?. Eur Respir J 2016; 48: Suppl. 60, 2652
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
An review of infection rates of invasive pleural procedures
Source: International Congress 2016 – Pleural diseases
Year: 2016
Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia?
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Pulmonary actinomycosis: Successful treatment with oral antibiotics
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Pleural infection: moving from treatment to prevention
Source: Eur Respir Monogr 2020; 87: 155-171
Year: 2020
Anti-tuberculosis drug concentrations and treatment outcomes in patients with both tuberculosis and HIV infection
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Could the early administration of antibiotics before admission improve the prognosis of pneumonia?
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Study of pleural empyema evolution depending on drainage size used
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Factors affecting treatment success in community acquired pneumonia (CAP)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Influence of long antibiotic therapy of lower respiratory tract infection (LRTI) on cytological characteristics of sputum
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Does standardized medical treatment for parapneumonic empyema (PE) in children reduces the need for surgical intervention?
Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects
Year: 2013
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures?
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Evaluation of drug induced liver injury due to anti tuberculous drugs in directly observed daily therapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept